We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
+7.38%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$261M
AUM Growth
+$13.9M
Cap. Flow
+$544K
Cap. Flow %
0.21%
Top 10 Hldgs %
27.65%
Holding
136
New
25
Increased
43
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
AAOI icon
Applied Optoelectronics
AAOI
+$6.45M
2
ASTH icon
Astrana Health
ASTH
+$4.45M
3
GLOB icon
Globant
GLOB
+$3.46M
4
CERT icon
Certara
CERT
+$2.64M
5
ALHC icon
Alignment Healthcare
ALHC
+$2.23M

Top Sells

Rank Stock Value
1
AIOT
PowerFleet Inc
AIOT
+$5.48M
2
FOUR icon
Shift4
FOUR
+$4.75M
3
OLED icon
Universal Display
OLED
+$3.56M
4
ARQ icon
Arq
ARQ
+$3M
5
HBM icon
Hudbay
HBM
+$2.77M

Sector Composition

Rank Sector Weight
1 Technology 32.35%
2 Healthcare 15.82%
3 Industrials 15.18%
4 Financials 9.75%
5 Consumer Discretionary 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DT icon
51
Dynatrace
DT
$14.2B
$2.11M 0.81%
48,732
+9,353
+24% +$436K
MHO icon
52
M/I Homes
MHO
$3.84B
$1.99M 0.76%
15,564
-1
-0% -$132
ALM
53
Almonty Industries
ALM
$4.02B
$1.8M 0.69%
204,353
-16
-0% -$118
GLOO
54
Gloo Holdings Inc
GLOO
$314M
$1.63M 0.62%
+285,882
New +$2.11M
ADPT icon
55
Adaptive Biotechnologies
ADPT
$3.97B
$1.48M 0.57%
+91,375
New +$1.49M
VKTX icon
56
Viking Therapeutics
VKTX
$4B
$1.45M 0.56%
41,222
-4
-0% -$142
VEU icon
57
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$1.41M 0.54%
19,212
GTLB icon
58
GitLab
GTLB
$6.58B
$1.4M 0.54%
37,358
+7,261
+24% +$314K
EVTL icon
59
Vertical Aerospace
EVTL
$173M
$1.34M 0.51%
+250,642
New +$1.27M
NOVT icon
60
Novanta
NOVT
$6.29B
$1.25M 0.48%
+10,506
New +$1.2M
CRL icon
61
Charles River Laboratories
CRL
$12.8B
$1.21M 0.46%
+6,059
New +$1.1M
BROS icon
62
Dutch Bros
BROS
$9.26B
$1.19M 0.46%
+19,476
New +$1.11M
ALDX icon
63
Aldeyra Therapeutics
ALDX
$93.5M
$1.16M 0.44%
+223,317
New +$1.15M
DNLI icon
64
Denali Therapeutics
DNLI
$3.97B
$1.11M 0.43%
+67,487
New +$1.14M
AIR icon
65
AAR Corp
AIR
$5.76B
$1.04M 0.4%
+12,613
New +$1.04M
USAR
66
USA Rare Earth Inc
USAR
$4.73B
$985K 0.38%
+82,783
New +$1.58M
WING icon
67
Wingstop
WING
$3.18B
$984K 0.38%
4,126
WULF icon
68
TeraWulf
WULF
$8.52B
$978K 0.37%
85,151
SOPH icon
69
SOPHiA GENETICS
SOPH
$647M
$973K 0.37%
+208,345
New +$944K
QUIK icon
70
QuickLogic
QUIK
$257M
$925K 0.35%
153,932
-15
-0% -$97
PLUG icon
71
Plug Power
PLUG
$3.04B
$799K 0.31%
405,700
-104,150
-20% -$272K
QTWO icon
72
Q2 Holdings
QTWO
$3.92B
$716K 0.27%
+9,920
New +$681K
VENU
73
Venu Holding Corp
VENU
$120M
$675K 0.26%
80,160
-4,536
-5% -$50.3K
EEM icon
74
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$644K 0.25%
11,777
DDI
75
DoubleDown Interactive
DDI
$588M
$534K 0.2%
61,900
-3
-0% -$27

Similar funds

1492 Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, 1492 Capital Management held 136 positions worth $261M, up 5.6% from $247M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

1492 Capital Management's Q4 2025 filing shows 25 new, 43 increased, 24 reduced and 21 closed positions. Its largest new stake was Applied Optoelectronics: 215,987 shares worth $7.53M. The largest sale was PowerFleet Inc, an estimated $5.48M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • 1492 Capital Management's largest Q4 2025 buy was Applied Optoelectronics: 215,987 shares worth $7.53M.
  • 1492 Capital Management added most to Certara in Q4 2025, an estimated $2.64M increase.
  • 1492 Capital Management's biggest Q4 2025 reduction was Arq, cutting an estimated $3M.
  • 1492 Capital Management fully exited PowerFleet Inc in Q4 2025, selling an estimated $5.48M.
  • 1492 Capital Management's ten largest holdings make up 28% of its $261M portfolio in Q4 2025.
  • 1492 Capital Management opened 25 new positions and closed 21 in Q4 2025.
  • 1492 Capital Management's portfolio value rose 5.6% quarter-over-quarter to $261M.

Based on 1492 Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.